This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

TIMOTHY R. FRANSON, MD
Indianapolis

MARK B. ADAMS, MD
Milwaukee

Arch Surg. 1988;123(7):913.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—We appreciate the interest and comments of Johnson and colleagues. Their initial commentary points out the disparate frequency of PCP in patients in our respective institutions. As with other infectious diseases, expectations for frequency of infectious complications in patients receiving transplants may be influenced by a variety of intercurrent variables, including serologic studies indicative of latent infection and medications. The epidemiology of PCP remains incompletely defined, and one may only speculate as to reasons accounting for differences in infection rates at various institutions. It should be noted from our report that PCP was virtually absent in our patients who received transplants before 1984, in contrast with the report by Jarwenko and colleagues² of a 4% incidence of infection in Houston. Regardless of relative baseline rates at an institution, an increased frequency of such events in any population should prompt diligent efforts to identify potential predisposing risk factors . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?